Five-Drug attack on blood cancer launches in clinical trial
NCT ID NCT07514832
Summary
This study is testing a new combination of five existing drugs as the first treatment for adults with acute myeloid leukemia (AML), a fast-growing blood cancer. The goal is to see if this intensive regimen is safe and effective at putting the cancer into remission. The trial will enroll 48 patients who have not yet received any treatment for their AML and are healthy enough for strong chemotherapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AML (ACUTE MYELOID LEUKEMIA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chinese PLA General Hospital
RECRUITINGBeijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.